12
Participants
Start Date
December 31, 2013
Primary Completion Date
February 28, 2015
Study Completion Date
June 30, 2015
Dociparstat sodium
"The following induction regimen was administered:~* Cytarabine (100 mg/m2/day) via continuous intravenous (IV) infusion 24 hours daily for 7 days.~* Idarubicin (12 mg/m2/day) IV on Days 1, 2, and 3.~* Dociparstat (4 mg/kg) given over 5 minutes IV, immediately after the idarubicin dose on Day 1, followed by a continuous IV infusion (0.25 mg/kg/hr for 24 hours daily) for a total of 7 days."
Lead Sponsor
Translational Drug Development
OTHER
Jazz Pharmaceuticals
INDUSTRY